Delivery Order SPE2DB20D3101-SPE2DB22FJ7X2

Award Date 5/11/22
Potential Completion Date 5/12/22
Potential Value $2.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of SUNOSI 150 MG TABLET 30S, an essential pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $5,183.78, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, valued at $1,732.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of SUNOSI 75 MG TABLET 30S, a prescription medication, with a completion date of April 17, 2024. The contract is a Delivery Order under a Firm Fixed Price structure and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,381.83 firm-fixed-price delivery order is for SUNOSI 75 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through November 13, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,752.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of SUNOSI 75 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of August 9, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has been awarded numerous...
This federal contract award, valued at $1,516.21, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of SUNOSI 150 MG TABLET 30S, a pharmaceutical product, to support the DLA's medical supply requirements. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 8, 2024. There is no set-aside designation for this award....
This federal contract award, valued at $4,156.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is a delivery order for the supply of SUNOSI 75 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of November 20, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,245.25 firm fixed price delivery order is for the supply of SUNOSI 150 MG TABLET 30S, a medication used in the treatment of conditions such as sleep disorders. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $4,088.10 with a firm fixed price. The contract is for the delivery of SUNOSI 150 MG TABLET 30S, a pharmaceutical product, with a period of performance through December 31, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,791.98, is for the delivery of SUNOSI 150 MG TABLET 30S. This is a firm fixed-price delivery order contract with a period of performance through March 31, 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sunosi 75 mg tablets. The contract, valued at $3,763.88, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FJ7X2
    Delivery Order

This federal contract award is for the delivery of 4557190584 - SUNOSI 75 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,465.82 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating full and open competition. The parent company of the prime contractor is Cencora, Inc., which also does business as Amerisourcebergen.

Generated 2/27/25, 10:46 AM